Evidence map›Paper›PMID 39194719›Full record

ArticleCurrent issues in molecular biology2024

Transgenic

Bobana Samardžija, Milan Petrović, Beti Zaharija, Marta Medija, Ana Meštrović, Nicholas J Bradshaw, Ana Filošević Vujnović, Rozi Andretić Waldowski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Genetic interaction ofFrontiers in neuroscience · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bobana SamardžijaFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51 000 Rijeka, Croatia.ORCID 0000-0001-7745-2337
Milan PetrovićFaculty of Informatics and Digital Technologies, University of Rijeka, Radmile Matejčić 2, 51 000 Rijeka, Croatia.
Beti ZaharijaFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51 000 Rijeka, Croatia.
Marta MedijaFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51 000 Rijeka, Croatia.
Ana MeštrovićFaculty of Informatics and Digital Technologies, University of Rijeka, Radmile Matejčić 2, 51 000 Rijeka, Croatia.ORCID 0000-0001-9513-9467
Nicholas J BradshawFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51 000 Rijeka, Croatia.ORCID 0000-0001-5581-8828
Ana Filošević VujnovićFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51 000 Rijeka, Croatia.
Rozi Andretić WaldowskiFaculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matejčić 2, 51 000 Rijeka, Croatia.ORCID 0000-0003-0375-0520

Funding

Alexander von Humboldt Foundation 1142747-HRV-IPCroatian Science Foundation DOK-2018-09-5395Croatian Science Foundation DOK-2020-01-8580Croatian Science Foundation IP-2018-01-9424University of Rijeka Foundation uniri-iskusni-biomed-23-206-8513
6 · The paper itself

Abstract

Disrupted in Schizophrenia 1 (DISC1) is a scaffold protein implicated in major mental illnesses including schizophrenia, with a significant negative impact on social life. To investigate if DISC1 affects social interactions in

Indexed as

Drosophila melanogasterhuman full-length Disrupted in Schizophrenia 1 (hfl-DISC1)locomotor activityredox regulationsocial interaction networks (SINs)

Identifiers

PMID39194719
PMCPMC11352338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.